Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Bavisant (JNJ-31001074) is a selective and orally active Human H3 receptor antagonist. Bavisant can be used in research on mechanisms of action, involving wakefulness and cognition and the treatment for ADHD.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 60.00 | |
5 mg | In stock | $ 147.00 | |
10 mg | In stock | $ 228.00 | |
25 mg | In stock | $ 389.00 | |
50 mg | In stock | $ 573.00 | |
100 mg | In stock | $ 816.00 | |
500 mg | In stock | $ 1,630.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 159.00 |
Description | Bavisant (JNJ-31001074) is a selective and orally active Human H3 receptor antagonist. Bavisant can be used in research on mechanisms of action, involving wakefulness and cognition and the treatment for ADHD. |
In vivo | Mean change from baseline in the total ADHD-RS-IV score at day 42 (primary efficacy endpoint) was -8.8 in the placebo group versus -9.3, -11.2, and -12.2 in the Bavisant 1 mg/day, 3 mg/day, and 10 mg/day groups, respectively; the change in the 10 mg/day group was not statistically superior to placebo, and hence statistical comparisons of the 1 mg/day and 3 mg/day groups with placebo based on a step-down closed testing procedure were not performed[1]. |
Synonyms | JNJ-31001074 |
Molecular Weight | 329.44 |
Formula | C19H27N3O2 |
CAS No. | 929622-08-2 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 13 mg/mL (39.46 mM)
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Bavisant 929622-08-2 GPCR/G Protein Immunology/Inflammation Neuroscience Histamine Receptor JNJ-31001074 Neurological disorders inhibit attention-deficit hyperactivity disorder ADHD cognition JNJ 31001074 wakefulness Inhibitor JNJ31001074 inhibitor